Outpatient Treatment With CoVid-19 With Prexablu
NCT04619290
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
46
Enrollment
OTHER_GOV
Sponsor class
Conditions
Sars Cov 2
Interventions
DRUG:
Sublingual Methylene blue
OTHER:
Control patients
Sponsor
Hospital Reg. Lic. Adolfo Lopez Mateos